Anti-CD20/CD30-CAR-T cell infusion

CD20/CD30-targeted CAR-T cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD20/CD30-CAR-T cell infusion, covering 2024-07-25 to 2024-07-25. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients. [EARLY_Phase 1]

See pricing